Getinge invites fund managers, analysts, and media to Q2 Report 2023 conference call
Getinge will issue its Q2 Report 2023 on July 18, 2023, at 08:00 a.m. CEST, followed by a conference call at 10:00-11:00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO.
Fund managers, analysts and media are invited to participate in the conference call.
To participate via teleconference, please register via this link (https://conference.financialhearings.com/teleconference/?id=200848). After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.
During the conference call a presentation will be held. To access the presentation through webcast, please use this link (https://ir.financialhearings.com/getinge-q2-2023). A recorded version can be accessed here (https://ir.financialhearings.com/getinge-q2-2023) for 3 years.
Lars Mattsson, Head of Investor Relations
Phone: +46(0)10 335 0043
E-mail: [email protected]
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in 135 countries.